Price Alert

Rigel Pharmaceuticals Inc... (RIGL)

NASDAQ: RIGL · Real-Time Price · USD

41.34

1.21 (3.02%)

At close: Sep 05, 2025, 3:59 PM

41.40

0.15%

After-hours: Sep 05, 2025, 07:07 PM EDT

3.02% (1D)

Bid	39.13
Market Cap	741.53M
Revenue (ttm)	267.92M
Net Income (ttm)	97.82M
EPS (ttm)	5.43
PE Ratio (ttm)	7.61
Forward PE	10.94
Analyst	Hold

Ask	41.45
Volume	462,992
Avg. Volume (20D)	471,633
Open	40.31
Previous Close	40.13
Day's Range	39.35 - 41.35
52-Week Range	12.66 - 43.72
Beta	1.21

About RIGL

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol RIGL

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RIGL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Rigel Pharmaceuticals Inc. is scheduled to release its earnings on Nov 6, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

+22.98%

Rigel Pharmaceuticals shares are trading higher af... Unlock content with Pro Subscription

4 months ago

+1.15%

RIGL stock has given up its prior gain. Rigel Pharmaceuticals shares were trading higher after the company reported Q1 financial results and beat its EPS and sales estimates.

News

1 week ago · zacks.com

Rigel Pharmaceuticals, Inc. (RIGL) Soars to 52-Week High, Time to Cash Out?

Rigel (RIGL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

3 weeks ago · youtube.com

Overlooked Stock: RIGL Nearly Doubles Stock in August

Rigel Pharmaceuticals (RIGL) is up 88% in August and more than tripled its stock price over the last year. The staggering upside rally began with a massive earnings beat and raised guidance.

3 weeks ago · seekingalpha.com

Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout

Rigel's Q2 results were outstanding, with revenue nearly doubling and net income surging, driven by strong commercial momentum for TAVALISSE, GAVRETO, and REZLIDHIA. Management raised 2025 guidance, e...

4 weeks ago · zacks.com

Earnings Estimates Moving Higher for Rigel (RIGL): Time to Buy?

Rigel Pharmaceuticals (RIGL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

4 weeks ago · zacks.com

Best Momentum Stock to Buy for August 8th

RIGL, APG and CLSK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 8, 2025.

4 weeks ago · zacks.com

5 Best Stocks With Relative Price Strength to Buy Right Now

LendingTree, RIGL, and others are standing out with strong relative price strength amid market volatility.

4 weeks ago · zacks.com

New Strong Buy Stocks for August 8th

INFU, RIGL, TROW, MITSY and NTRS have been added to the Zacks Rank #1 (Strong Buy) List on August 8, 2025.

4 weeks ago · zacks.com

Rigel Pharmaceuticals (RIGL) Just Flashed Golden Cross Signal: Do You Buy?

From a technical perspective, Rigel Pharmaceuticals, Inc. (RIGL) is looking like an interesting pick, as it just reached a key level of support. RIGL's 50-day simple moving average crossed above its 2...